glp-1 agonist alzheimer's improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in disease ๐ ๐๐๐ฎ๐ซ๐จ๐ฉ๐๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ข๐ฌ๐ญ'๐ฌ ๐๐๐ค๐ ๐จ๐ง ๐๐๐-๐๐ฌ
Description
Then, mice were refed until the day of treatment (at least 2 weeks)
A sensitivity analysis excluding the ITCA trial yielded consistent results (HR (95%CI): 0.86 (0.800.94)

It is appropriate when symptoms are mild and tolerable

Vincenza Cifferelli, and Dr
